Can a Mom's shot shield her baby from RSV?

NCT ID NCT07249320

Summary

This study is checking how well the ABRYSVO RSV vaccine works when given to pregnant people to protect their babies after birth. Researchers will review the medical records of nearly 40,000 mothers and infants to compare health outcomes for babies whose mothers got the vaccine versus those who did not. They are looking to see if the vaccine reduces babies' risk of serious RSV lung infections, hospital visits, and other illnesses in their first two years.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Pfizer

    New York, New York, 10001, United States

Conditions

Explore the condition pages connected to this study.